Related references
Note: Only part of the references are listed.Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis
Srinivasan Dasarathy et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial
Curtis K. Argo et al.
JOURNAL OF HEPATOLOGY (2015)
No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial
Arun J. Sanyal et al.
GASTROENTEROLOGY (2014)
Effects of Purified Eicosapentaenoic and Docosahexaenoic Acids in Nonalcoholic Fatty Liver Disease: Results From the WELCOME* Study
Eleonora Scorletti et al.
HEPATOLOGY (2014)
LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis
Mitsuko Hara et al.
SPRINGERPLUS (2014)
Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Philip C. Calder
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis
Christopher Savard et al.
HEPATOLOGY (2013)
Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis
George N. Ioannou et al.
JOURNAL OF LIPID RESEARCH (2013)
Docosahexaenoic Acid Attenuates Hepatic Inflammation, Oxidative Stress, and Fibrosis without Decreasing Hepatosteatosis in a Ldlr-/- Mouse Model of Western Diet-Induced Nonalcoholic Steatohepatitis
Christopher M. Depner et al.
JOURNAL OF NUTRITION (2013)
Hepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans
Michiko Itoh et al.
PLOS ONE (2013)
Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis
Keisuke Kakisaka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
Naga Chalasani et al.
GASTROENTEROLOGY (2012)
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
Matteo Nicola Dario Di Minno et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Melanocortin 4 Receptor-Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis
Michiko Itoh et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Eicosapentaenoic Acid Attenuates Progression of Hepatic Fibrosis with Inhibition of Reactive Oxygen Species Production in Rats Fed Methionine- and Choline-Deficient Diet
Satoshi Kajikawa et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Generalizability of the Nonalcoholic Steatohepatitis Clinical Research Network Histologic Scoring System for Nonalcoholic Fatty Liver Disease
Ravi Juluri et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Mechanisms and clinical implications of hepatocyte lipoapoptosis
Sophie C. Cazanave et al.
CLINICAL LIPIDOLOGY (2010)
Antiobesity Effect of Eicosapentaenoic Acid in High-Fat/High-Sucrose Diet Induced Obesity Importance of Hepatic Lipogenesis
Ayumi Sato et al.
DIABETES (2010)
Highly Purified Eicosapentaenoic Acid Ethyl Ester Prevents Development of Steatosis and Hepatic Fibrosis in Rats
Satoshi Kajikawa et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
Melanocortin-4 Receptor Expression in a Vago-vagal Circuitry Involved in Postprandial Functions
Laurent Gautron et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2010)
Adipokines in Liver Diseases
Fabio Marra et al.
HEPATOLOGY (2009)
Non-alcoholic steatohepatitis and animal models: Understanding the human disease
Marta Varela-Rey et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis
Takeharu Asano et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Eicosapentaenoic acid ameliorates steatollepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice
Hajime Ishii et al.
JOURNAL OF HEPATOLOGY (2009)
Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis
Naoki Tanaka et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Activation of peroxisome proliferator-activated receptor α by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation
Claire Z. Larter et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Hepatic free fatty acids accumulate in experimental steatohepatitis: Role of adaptive pathways
Claire Z. Larter et al.
JOURNAL OF HEPATOLOGY (2008)
Polyunsaturated fatty acids as antioxidants
Doriane Richard et al.
PHARMACOLOGICAL RESEARCH (2008)
Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model
Yoshihiro Kamada et al.
JOURNAL OF HEPATOLOGY (2007)
Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects
Michiko Itoh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
A model of insulin resistance and nonalcoholic steatohepatitis in rats -: Role of peroxisome proliferator-activated receptor-α and n-3 polyunsaturated fatty acid treatment on liver injury
Gianluca Svegliati-Baroni et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study
M Capanni et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-γ-dependent mechanism in mice
S Neschen et al.
DIABETES (2006)
Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis
D Wang et al.
ENDOCRINOLOGY (2006)
Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet
P Flachs et al.
DIABETOLOGIA (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells
S Aleffi et al.
HEPATOLOGY (2005)
Divergence of melanocortin pathways in the control of food intake and energy expenditure
N Balthasar et al.
CELL (2005)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Blockade of CCR2 ameliorates progressive fibrosis in kidney
K Kitagawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
Y Kamada et al.
GASTROENTEROLOGY (2003)
Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats
S Shklyaev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis
AE Feldstein et al.
GASTROENTEROLOGY (2003)
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
AM Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease
PM Kris-Etherton et al.
CIRCULATION (2002)
Leptin is essential for the hepatic fibrogenic response to chronic liver injury
IA Leclercq et al.
JOURNAL OF HEPATOLOGY (2002)
Impaired liver regeneration in mice by lipopolysaccharide via TNF-α/kallikrein-mediated activation of latent TGF-β
K Akita et al.
GASTROENTEROLOGY (2002)
Leptin in hepatic fibrosis:: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice
NK Saxena et al.
HEPATOLOGY (2002)
The biochemistry of n-3 polyunsaturated fatty acids
DB Jump
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-β
M Okuno et al.
GASTROENTEROLOGY (2001)
Share Paper
